TREATING SARCOPENIC OBESITY IN THE ERA OF INCRETIN THERAPIES: PERSPECTIVES AND CHALLENGES

Descargar Publicación
CagriSema drives weight loss in rats by reducing energy intake and preserving energy expenditure Long-acting PYY3−36 analogue with semaglutide for obesity: from preclinical assessment through randomized clinical studies